AtriCure Inc
NASDAQ:ATRC

Watchlist Manager
AtriCure Inc Logo
AtriCure Inc
NASDAQ:ATRC
Watchlist
Price: 37.87 USD 0.08% Market Closed
Market Cap: 1.9B USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+37%
Revenue
Forecast
+14%
Operating Income
Forecast
N/A
Net Income
Forecast
N/A

Wall Street
Price Targets

ATRC Price Targets Summary
AtriCure Inc

Wall Street analysts forecast ATRC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ATRC is 52.02 USD with a low forecast of 40.4 USD and a high forecast of 63 USD.

ATRC Lowest Forecast
Wall Street Target
40.4 USD
7% Upside
ATRC Average Forecast
Wall Street Target
52.02 USD
37% Upside
ATRC Highest Forecast
Wall Street Target
63 USD
66% Upside
Lowest
Price Target
40.4 USD
7% Upside
Average
Price Target
52.02 USD
37% Upside
Highest
Price Target
63 USD
66% Upside
AtriCure Inc Competitors:
Price Targets
7779
Cyberdyne Inc
16% Upside
688580
Nanjing Vishee Medical Technology Co Ltd
5% Downside
688301
iRay Technology Co Ltd
5% Downside
DIA
DiaSorin SpA
20% Upside
7779
Cyberdyne Inc
16% Upside
688580
Nanjing Vishee Medical Technology Co Ltd
5% Downside
688301
iRay Technology Co Ltd
5% Downside
DIA
DiaSorin SpA
20% Upside
SYK
Stryker Corp
13% Upside
7733
Olympus Corp
23% Upside
ALKLH
Klea Holding
124% Upside
7817
Paramount Bed Holdings Co Ltd
5% Upside

Revenue
Forecast

Revenue Estimate
AtriCure Inc

For the last 13 years the compound annual growth rate for AtriCure Inc's revenue is 16%. The projected CAGR for the next 3 years is 14%.

16%
Past Growth
14%
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
AtriCure Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
AtriCure Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-41%
Average Miss
What are analyst estimates?

See Also

Summary
ATRC intrinsic value, competitors valuation, and company profile.
DCF Valuation
ATRC stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ATRC stock valuation using valuation multiples.
Wall Street Estimates
ATRC price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ATRC stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ATRC's stock price target?
Price Target
52.02 USD

According to Wall Street analysts, the average 1-year price target for ATRC is 52.02 USD with a low forecast of 40.4 USD and a high forecast of 63 USD.

What is AtriCure Inc's Revenue forecast?
Projected CAGR
14%

For the last 13 years the compound annual growth rate for AtriCure Inc's revenue is 16%. The projected CAGR for the next 3 years is 14%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 278,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.